Dorsavi
- Short interest
- 0.01%
- −0.05 pp 30d
- as of 4 June 2026
- Reported shorts
- 124.8K
- Shares on issue
- 1.210B
Dorsavi (DVL) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $1.6MM (source: ASX (Markit))vs $1.5MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- −$8.5MM (source: ASX (Markit))vs −$1.5MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- −$0.008T (source: Derived: trailing 12 months at year end)vs −$0.002 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- +5.8%FY
- EPS YoY
- n/aTTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of DVL June 2026 Appendix 4E and Annual Report, 31 Aug 2026
DorsaVi reported revenue of $1.59 million for FY2026, up 5.8% from the prior year, but its net loss widened sharply by 461.7% to $8.52 million, reflecting increased investment in technology and semiconductor development. No dividend was paid or declared. The company completed a $5.0 million placement and is advancing its RRAM and neuromorphic programs, with net assets rising to $4.34 million.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- −535.4%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $1.6MM (source: ASX (Markit)) | $1.5MM (source: ASX (Markit)) | $1.3M | $1.8M |
| Gross profit | n/a | n/a | $1.2M | $1.6M |
| Operating income | n/a | n/a | −$1.7M | −$2.3M |
| EBITDA | n/a | n/a | −$1.6M | −$1.9M |
| EBIT | n/a | n/a | −$1.7M | −$2.1M |
| Interest expense | n/a | n/a | $22.3K | $239.0K |
| Pretax income | n/a | n/a | −$1.7M | −$2.3M |
| Tax | n/a | n/a | −$456.5K | −$486.1K |
| NPAT | −$8.5MM (source: ASX (Markit)) | −$1.5MM (source: ASX (Markit)) | −$1.2M | −$1.8M |
| Net interest income | n/a | n/a | −$11.5K | −$239.0K |
| EPS basic | −$0.008T (source: Derived: trailing 12 months at year end) | −$0.002 | −$0.002 | −$0.004 |
| EPS diluted | −$0.008T (source: Derived: trailing 12 months at year end) | −$0.002 | −$0.002 | −$0.004 |
| Shares | n/a | n/a | 615.2M | 553.2M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- DVL June 2026 Appendix 4E and Annual ReportAnnual Results31 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Apr 2026via asx_announcements
- Appendix 4D and Half Year Financial ReportHalf Year Results26 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Jan 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Oct 2025via asx_announcements
- Annual Report to ShareholdersAnnual Report29 Sep 2025via asx_announcements
- DVL June 2025 Appendix 4EAnnual Results29 Aug 2025via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jul 2025via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Apr 2025via asx_announcements
Showing 10 of 31 reports